Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (434)	12/7/2003 10:21:43 PM
From: Jibacoa	Read Replies (1) of 3722

LSCP Has had a good run since its UPTREND started on April 23 from the 4.20 level.<g> The stock was up more than 400% at its H of 18.15 on December 2. On Friday in spite of the general market, it showed some signs that it wants to retest its December 2 Hs.<g> The nearest support is now at 15.90 and resistance at 16.50 The revenues for the September Q were up around 35% and earnings were $0.03 vs $0.01 For the December Q the company is expecting to report $0.05 vs. $0.01 and then to more than double its earnings the following year. In spite of its already good gains this year, it seems worthwhile to keep an eye on LSCP as long as it can hold the 15.90 level. With the caveat that the stock hasn't closed its November 24 upgap.<g> siliconinvestor.com siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next